Flupyradifurone is a Butenolide insecticide belonging to IRAC Group 4D, primarily used for the control of sucking pests such as aphids, whiteflies, leafhoppers, and psyllids. The current IRAC classification groups it with Acetamiprid, Imidacloprid, Thiamethoxam, Dinotefuran, and other Group 4A products, but they still fall under the broader IRAC Group 4 nAChR competitive modulators.

For importers or distributors preparing to enter this market, the real question to address is not:

“Can flupyradifurone control whiteflies?”

but rather:

“Can I legally complete the registration of this product, and do local pests, crops, resistance profiles, MRLs, and pricing structures sufficiently support a new Flupyradifurone program?”

This is particularly important because Flupyradifurone currently still possesses distinct characteristics regarding registration data, data exclusivity, technical sources, and market access. Taking the United States as an example, the EPA has extended the protection period for flupyradifurone’s exclusive-use data until January 15, 2028. This date pertains to U.S. regulatory data protection and is not a globally uniform patent expiration date.

Therefore, the correct sequence for market entry should be:

Regulatory access → data/IP status → pest needs → crop value → resistance → MRL → product portfolio → formulation and suppliers → commercial return

rather than requesting a quote first.

Flupyradifurone Market Entry Quick Assessment

Assessment Criteria Quick Answer
Chemical Class Butenolide
IRAC Group Group 4D
Primary Mode of Action nAChR
Target Pest Groups Aphids, Whiteflies, Leafhoppers, Psyllids
Product Market Positioning Focuses on sucking pests
Relationship with Group 4A Different subgroups, but still part of Group 4
Major Resistance Risks Cross-resistance is related to population and mechanism
Major Registration Risks Data rights, technical source, local dossier
MRL Significance Particularly high for fruits, vegetables, and export crops
Conclusions on Pollinating Insects Cannot simply be marketed as “bee-safe”
Core Business Issues Is the local market worth the registration costs?

If any of the three factors—regulatory access, data rights, or technical source—remain unclear, the project typically has not yet reached the stage of discussing packaging and bulk pricing.

Can we enter the Flupyradifurone market?

In which markets has Flupyradifurone already been commercialized?

Flupyradifurone has been commercialized in several major agricultural markets, but the conditions for active substance, product authorization, and registration vary by market.

According to U.S. EPA records, Flupyradifurone was first registered on January 15, 2015.

The current situation in the EU is different.

The active substance approval for flupyradifurone has been extended to June 9, 2029, as the renewal risk assessment has not yet been completed and additional time is needed to finalize the follow-up evaluation process.

This illustrates that:

Active substance approval, specific product registration, and eligibility for commercialization in a market are not the same concept.

An importer cannot automatically assume that the same generic registration pathway exists in their target market simply because flupyradifurone is already being sold in another country.

Can a new importer register flupyradifurone directly?

One cannot draw conclusions based solely on the fact that the active ingredient is already on the market.

What really needs to be checked is:

  • Local active substance status
  • Registration pathway
  • Regulatory data protection
  • Data access rights
  • Technical source requirements
  • Patent / FTO
  • Formulation-related rights
  • Local efficacy/residue/toxicology requirements

Taking the United States as an example, the EPA has extended the protection period for certain exclusive-use data for flupyradifurone to January 15, 2028.

This means that during the applicable protection period, new applicants cannot simply rely on the protected data to complete registration unless they meet the corresponding conditions stipulated by U.S. law.

Data protection rules, durations, and methods of data reliance in other countries may differ significantly from those in the United States.

Is Flupyradifurone now a generic active ingredient?

There is no single, universal “yes” or “no” answer.

Each of the following must be examined separately:

  1. patents related to the active ingredient;
  2. formulation patents;
  3. use patents;
  4. rights related to manufacturing/processes;
  5. regulatory data protection;
  6. local technical-source acceptance.

Even if there are no foundational patents in a particular country that prevent entry for the active ingredient itself, this does not mean that any formulation, mixture, or use claim has complete FTO.

Therefore, a more professional approach is not to ask:

“When does the patent for this compound expire?”

but rather:

“Does the specific product we plan to register and sell have FTO in the target market, and is there a legally viable registration data pathway available?”

Are data exclusivity and patents the same thing?

No.

These are the two concepts most easily confused when evaluating the Flupyradifurone project.

Patents primarily protect the invention itself, such as:

  • Molecule
  • Formulation
  • Manufacturing process
  • Combination
  • Specific use

In contrast, regulatory data protection / exclusive-use data protects the research data that a company submits to regulatory authorities for registration.

In the United States, the EPA explicitly stipulates that protected data within the exclusive-use period cannot be directly relied upon by other applicants without the permission of the data rights holder.

Therefore:

Patent freedom ≠ Data freedom

The reverse is also true.

Due diligence must be conducted separately for each issue.

Can a foreign flupyradifurone registration directly support a domestic registration?

Generally, they are not directly equivalent.

Foreign registrations can help clarify:

  • Crop positioning
  • Pest spectrum
  • Formulation
  • Application pattern
  • PHI
  • Product specification

However, local regulatory authorities may require:

  • Technical source
  • Toxicology
  • Ecotoxicology
  • Efficacy
  • Residue
  • MRL
  • Label
  • Formulation
  • Local trials

Therefore, foreign registration should be viewed as:

Reference material

rather than:

Automatic eligibility for registration.

What exactly is flupyradifurone?

Which IRAC Group does flupyradifurone belong to?

Flupyradifurone belongs to IRAC Group 4D.

In the IRAC 2026 MoA classification:

  • Group 4A = Neonicotinoids
  • Group 4C = Sulfoximines
  • Group 4D = Butenolides
  • Flupyradifurone is currently the representative active ingredient in Group 4D.

It primarily acts on the insect’s nAChR and is classified as a neurotoxic insecticide.

Is flupyradifurone a neonicotinoid?

No.

Flupyradifurone belongs to the butenolide chemical class, not Group 4A neonicotinoids.

However, one cannot conclude from this that:

“It has a completely different mechanism of action (MoA) from neonicotinoids.”

Because:

Both Group 4A and Group 4D belong to the larger IRAC Group 4 nAChR competitive modulators.

Therefore, the correct understanding should be:

They belong to different chemical subgroups, but their mechanisms of action are not completely independent within the larger group.

Is flupyradifurone a systemic insecticide?

Flupyradifurone is typically positioned as an insecticide for sucking pests with systemic and translaminar properties.

This helps the product reach:

  • Whiteflies on the undersides of leaves
  • Aphids that feed on plant sap
  • Leafhoppers
  • Psyllids

and other target pests.

However, specifically:

  • Foliar
  • Soil
  • Drip
  • Root uptake

Whether and how the product may be used should be determined by the label of the locally registered product.

The fact that the active ingredient has systemic properties does not mean that all application methods should automatically be included in promotional materials.

Which pest markets are suitable for flupyradifurone?

Which pests does flupyradifurone primarily control?

Its clearest commercial role is in the management of sucking pests.

The key targets listed by the U.S. EPA at the time of initial registration include:

  • Aphids
  • Whiteflies
  • Thrips
  • Psyllids

It covers a wide range of crops, including citrus, cotton, and potatoes.

From a distributor’s perspective, the markets that are typically worth evaluating most closely are:

  • Aphid-intensive markets
  • Whitefly-intensive markets
  • Psyllid markets
  • Leafhopper markets
  • High-value horticultural and fruit and vegetable markets

rather than positioning flupyradifurone as a general-purpose, broad-spectrum insecticide.

Is flupyradifurone suitable for the whitefly market?

Whitefly is one of the most important commercial markets for flupyradifurone.

Especially in:

  • Vegetables
  • Greenhouse crops
  • Cotton
  • Horticulture
  • Virus-sensitive crops

In these markets, whiteflies not only cause direct feeding damage but may also act as vectors for viruses.

However, what importers really need to confirm is:

To which Groups has the local Bemisia tabaci population currently developed resistance?

If the market has long been highly dependent on Group 4 insecticides, then the actual value of flupyradifurone must be based on local susceptibility data, rather than judged solely on the product’s historical reputation.

Is flupyradifurone suitable for the aphid market?

Yes, but this must be evaluated in conjunction with the existing product portfolio.

If distributors already carry:

  • Acetamiprid
  • Thiamethoxam
  • Dinotefuran
  • Imidacloprid

then the question should not simply be:

“Can flupyradifurone also control aphids?”

but rather:

“Does Group 4D add sufficient technical and commercial differentiation to my aphid product line?”

If existing products already cover most of the low-cost aphid market, flupyradifurone will likely need to rely on:

  • High-value crops
  • Resistance positioning
  • Premium channel
  • IPM
  • Export crop programs

to demonstrate its commercial value.

For insights on how existing Group 4A products achieve commercial differentiation, refer to SunAgro’s Acetamiprid and Dinotefuran Product Positioning Analysis.

Is Flupyradifurone a Caterpillar product?

It is not its core commercial positioning.

If the primary local pests are:

  • Armyworms
  • Bollworms
  • Borers
  • Other Lepidoptera larvae

Then priority should be given to evaluating active ingredients and modes of action (MoA) specifically targeting these pests.

The value proposition for the flupyradifurone product line should be built around:

the sucking pest market

rather than artificially expanding it to cover all major agricultural pests.

Which crop markets are most worth evaluating for flupyradifurone?

Is flupyradifurone better suited for high-value crops?

Commercial evaluation is generally more worthwhile in high-value markets where sucking pest pressure is significant.

Typical areas include:

  • Vegetables
  • Greenhouse crops
  • Citrus
  • Fruit crops
  • Berries
  • Export horticulture
  • Markets with high pest pressure, such as cotton

The reason is not that these crops “must use Flupyradifurone.”

Rather, these markets typically more easily meet the following commercial conditions:

High pest damage + high resistance costs + high product value

If a market is primarily characterized by:

  • field crops that are extremely price-sensitive;
  • Group 4A generic products are already highly mature;
  • distributors can only compete on the basis of the lowest cost per hectare;

then even if Flupyradifurone is technically effective, the commercial return may not necessarily justify the investment required for registration.

Why are virus-vector markets worth paying attention to?

Many species of aphids, whiteflies, leafhoppers, and psyllids not only feed directly on plant sap but may also transmit plant viruses or other pathogens.

For these types of markets, distributors cannot evaluate products by calculating only:

Pest mortality rate

They should also consider:

  • Cessation of feeding
  • Vector pressure
  • Crop value
  • Infection window
  • Application timing

However, “pest control” should not automatically be marketed as “preventing all virus transmission.”

The final claim must align with local labels and evidence.

Flupyradifurone Resistance FAQ

Can flupyradifurone control neonicotinoid-resistant whiteflies?

Some populations may remain susceptible, but this cannot be guaranteed globally.

One of the early commercial advantages of flupyradifurone was its potential to remain active against certain populations of sucking pests that had already developed neonicotinoid resistance.

However, subsequent research has demonstrated that:

Flupyradifurone resistance can also develop on its own.

In a study on Bemisia tabaci, a laboratory-selected resistant strain exhibited a significantly high level of resistance to flupyradifurone and moderate cross-resistance to imidacloprid. The study also found that P450 and GST metabolic mechanisms were involved.

Therefore, the following claim should not be made:

“Flupyradifurone is effective against all neonicotinoid-resistant whiteflies.”

The correct statement should be:

Specific efficacy depends on the local population and its resistance mechanism.

Does flupyradifurone itself induce resistance?

Yes.

Any insecticide with a specific mode of action (MoA) that is applied repeatedly over the long term can create selective pressure.

Flupyradifurone is not a product that “does not induce resistance.”

Distributors should focus on understanding:

  • Local whitefly resistance history
  • Historical usage intensity of Group 4
  • Current effective dose performance
  • Field failures
  • Whether other effective IRAC Groups exist

Only then should a decision be made regarding the role Flupyradifurone should play in the product line:

Flagship product

Or:

A tool for use within a limited window.

Can Flupyradifurone be rotated with Acetamiprid?

Switching from Group 4A to Group 4D cannot simply be described as a rotation between completely different modes of action (MoA).

The IRAC Group 4 resistance management guidelines state that although the various subgroups of Group 4 have different chemical structures, they act on the same primary receptor system, and potential cross-resistance must be considered.

Therefore:

Flupyradifurone = Group 4D

Acetamiprid = Group 4A

They are indeed different subgroups.

However:

subgroup diversity ≠ complete MoA diversity

If the true goal is to reduce selection pressure on Group 4, a more reasonable approach would be to evaluate other IRAC Groups that are effective locally.

Can flupyradifurone add value to the Group 4A product line?

Yes, but the value must be specifically defined.If a distributor already sells multiple Group 4A products, flupyradifurone may add:

  • Chemistry from a different subgroup
  • Different formulation/application positioning
  • Opportunities for actual control in certain resistant populations
  • High-value crop positioning
  • Premium sucking-pest segment

However, it cannot be said that:

“Adding Flupyradifurone provides a complete resistance rotation.”

If the market truly lacks another IRAC Group—for example, if the aphid market requires a different mode of action— it would be appropriate to simultaneously evaluate product directions such as Flonicamid Group 29, rather than continuing to indefinitely increase Group 4 SKUs. IRAC currently classifies Flonicamid as Group 29.

Flupyradifurone and Pollinators, IPM

Is Flupyradifurone Safe for Bees?

The phrase “absolutely safe” should not be used as a global marketing slogan.

During its initial registration in 2015, the EPA reviewed a large number of pollinator studies and noted that, in laboratory studies, flupyradifurone exhibited low acute toxicity to adult honeybees, and no adverse effects on colony performance or overwintering ability were observed under the conditions of use evaluated.

This is an important product characteristic.

However, it cannot be simplified to:

“Safe for use during the active season of bees under any circumstances.”

Actual risk is also influenced by:

  • Dose
  • Application timing
  • Flowering stage
  • Route of exposure
  • Tank-mix partners
  • Local label

These factors.

Therefore, distributor promotional materials should prioritize the use of:

A relatively favorable pollinator profile under registered conditions of use

Rather than:

Bee-safe

Can flupyradifurone be used during the flowering period?

You must check the specific label.

Requirements may vary by country, crop, and application method.

Even if a registration permits use at a specific flowering stage, this does not automatically apply to:

  • other countries
  • other crops
  • other doses
  • Other tank mixes

In particular, when the product is mixed with fungicides, adjuvants, or other insecticides, local pollinator restrictions should be rechecked.

Is flupyradifurone suitable for IPM?

It can be incorporated into certain IPM systems, but this should not be interpreted to mean it has no impact on all beneficial insects.The product’s value in certain registration systems includes:

  • Targeting sucking pests
  • Systemic activity
  • Relatively good selectivity toward certain beneficial organisms
  • More precise timing in conjunction with biological control systems

However, the response varies:

  • Predator
  • Parasitoid
  • Pollinator

Responses to the same product are not entirely consistent.

Therefore, the correct statement should be:

Flupyradifurone can play a role in locally validated IPM programs.

Rather than:

“Flupyradifurone is harmless to beneficial insects.”

MRLs and Export Markets FAQ

Why should MRLs be checked before registering Flupyradifurone?

Because it is well-suited for many crops that happen to belong to residue-sensitive, high-value markets.For example:

  • Citrus
  • Fruits
  • Vegetables
  • Berries
  • Greenhouse produce
  • Export horticulture

For these crops, the project cannot simply ask:

“Can it be registered locally?”

It must also determine:

“Where will the harvested produce ultimately be sold?”

In 2026, the EU still updated certain MRLs for flupyradifurone, affecting multiple product categories such as citrus, fruits, and nuts.

Therefore, the correct sequence should be:

Crop → Pest → Rate → PHI → Local MRL → Export MRL → Registration, rather than checking export residue standards only after registration is complete.

Does compliance with local PHI standards guarantee compliance with export market standards?

No, it does not.

PHI is a critical usage condition on the registered label, but local label compliance ≠ destination-market MRL compliance. If locally produced:

  • Citrus
  • Vegetables
  • Fruit
  • Berries

are exported in large quantities to the EU, the Middle East, Russia, the GCC, or other markets, distributors should check major trade destinations in advance when determining crop registration priorities.

Otherwise, even a pesticide program that is fully compliant locally may still pose a residue risk to exporters.

Flupyradifurone Formulation and Product Selection FAQ

Is Flupyradifurone 200 g/L SL a common product formulation?

200 g/L SL is a relatively common Flupyradifurone formulation in several commercial markets at present, but it should not be considered the only specification globally.

Importers should confirm the following during their assessment:

  • Local registration specifications
  • Concentration expression
  • Formulation type
  • Dose
  • Pack size
  • Registered crops
  • Application route

Rather than simply replicating the 200 g/L SL specification for their own market just because it is sold in other countries.

Are all Flupyradifurone SL products the same?

Products are not automatically considered fully equivalent simply because they share the same active ingredient and nominal concentration.

Further verification is required:

  • Technical source
  • Active ingredient assay
  • Relevant impurities
  • Formulation composition
  • pH
  • Storage stability
  • Packaging compatibility
  • Low/high temperature stability
  • Batch consistency

This is especially true for products requiring long-term registration maintenance: registration sample quality and the quality of commercial batches three years later must both be stable.

Why is the technical source particularly important?

Because the market-entry issues for flupyradifurone are not limited to formulation concerns.

The technical source may involve:

  • Regulatory acceptance
  • Equivalence
  • Impurity profile
  • Manufacturing source
  • Data access
  • IP/FTO
  • Registration consistency

Therefore, once the dossier has been initiated, do not casually treat:

“a slightly cheaper TC supplier”

as a simple procurement alternative once the dossier has already been initiated.A source change may require a reassessment of the entire registration project.

What information should importers request?

Specific dossier requirements vary by country, but a clear data framework should be established at least in the early stages of the project.

Common preparatory materials include:

  • Manufacturer identity
  • Technical source information
  • Product specification
  • COA
  • SDS / MSDS
  • TDS
  • Formulation information
  • Relevant impurity information
  • Analytical method
  • Stability information
  • Packaging data
  • Available registration data
  • Data-right status
  • Patent / FTO review results
  • MRL / residue strategy

The most important factor here is not the volume of documentation.

Rather, it is crucial to ensure that:the source, manufacturer, formulation, specification, and registration strategy are consistent with one another.SunAgro’s existing import documentation and supplier audit materials can serve as a starting point for further procurement audits. For example, its News Center has published articles such as “What Documents Should Agrochemical Distributors Request Before Importing?” and “How Importers Evaluate Agrochemical Suppliers Before Registration”.

Is a Flupyradifurone Project Worth Pursuing?

Before committing to registration fees, it is recommended to complete the following assessments:

Market Entry Check Why It Matters
Local regulatory status Determines whether registration can proceed
Data exclusivity Determines whether relevant data can be legally relied upon
Patent / FTO Determines the degree of commercial freedom
Technical source Determines whether the dossier is viable
Major sucking pests Determines actual demand
Whitefly / Aphid resistance Determines technical value
Existing Group 4 products Assess SKU overlap
Other IRAC Group products Assess true MoA diversity
Area under high-value crops Assess potential for premium products
Local MRL Assess local residue compliance
Export MRL Assess export crop risk
Pollinator restrictions Impact on application window
Registration cost Assess investment
Expected annual volume Assess return on investment
Supplier continuity Protect long-term registration investment

An attractive active ingredient does not necessarily equate to an attractive registration project.

Frequently Asked Questions on Flupyradifurone Market Entry

Is Flupyradifurone Better Than Acetamiprid?

It’s Not That Simple to Compare Them.

Acetamiprid belongs to Group 4A.

Flupyradifurone belongs to Group 4D.

Both may enter:

  • Aphid
  • Whitefly
  • Leafhopper

markets, but their commercial positioning may be entirely different.

What really should be compared:

  • Local susceptibility
  • Crop registration
  • Cost per hectare
  • Application system
  • MRL
  • Premium capacity
  • Existing portfolio

rather than “which molecule is stronger.”

If Acetamiprid, Dinotefuran, and Thiamethoxam are already available, is Flupyradifurone still needed?

It may be needed, or it may simply be another SKU for sucking pests.

Situations where it is worth adding include:

  • The market requires Group 4D commercial positioning
  • High-value crops represent a sufficiently large market
  • Control efficacy of some Group 4A products has declined
  • Different registered crops
  • Different application systems
  • Premium channels can support the price

Situations where it may not be worth adding include:

  • Complete overlap between pests and crops
  • The local market only accepts the lowest price
  • Resistance benefit cannot be demonstrated
  • Registration costs are very high
  • Market size is insufficient

Should flupyradifurone be marketed as a resistance-management product?

Its Group 4D classification and resistance-management role can be discussed, but it should not be described as “resistance-free” or “completely free of Group 4 cross-resistance.”The most accurate commercial statement is:

Flupyradifurone offers Group 4D chemistry distinct from Group 4A neonicotinoids, but local resistance mechanisms and susceptibility must still be evaluated.

When is a market not yet suitable for flupyradifurone entry?

Entry should be postponed under the following circumstances:

  • Unclear data rights
  • Patent/FTO not verified
  • Technical source not yet determined
  • Registration pathway unclear
  • Insufficient demand for target pests
  • Too small an area of high-value crops
  • High overlap with existing products
  • Export MRLs do not align
  • Competition relies solely on low prices
  • Supplier cannot provide long-term support for the dossier or a consistent source

Any one of these risks could turn “a technically excellent product” into “a product not worth registering from a commercial standpoint.”

Assessment of the Flupyradifurone Market Entry Project

The market value of flupyradifurone cannot be judged solely based on the three labels: Whitefly, Aphid, or Group 4D.For importers and distributors, a more reasonable market entry strategy is:

  1. First, confirm regulatory access
  2. Confirm data rights and patents/FTO
  3. Confirm technical source
  4. Evaluate major sucking pests
  5. Check for Group 4 resistance
  6. Analyze overlap with existing portfolio
  7. Confirm local MRLs and export MRLs
  8. Check conditions for pollinator and IPM use
  9. Evaluate registration costs and annual volume
  10. Finally, discuss formulation, packaging, and price

When SunAgro discusses new crop protection products with importers, distributors, and registration partners, it focuses more on whether there are clear technical and commercial gaps in the target market rather than simply increasing the number of active ingredients.

If you are evaluating the Flupyradifurone project, we recommend first preparing the following:

  • Target country
  • Local registration status
  • Major crops
  • Major aphid, whitefly, psyllid, and leafhopper problems
  • Current Group 4 product portfolio
  • Known resistance status
  • Major export crops and target markets
  • Planned formulation
  • Registration pathway
  • Technical source
  • Estimated annual demand
  • Target price range
  • Data/IP status

The most promising markets for flupyradifurone are not simply those with “a lot of whiteflies.”

Rather:

Markets with clear regulatory access, favorable data/IP conditions, significant economic damage caused by sucking pests, a clear gap in existing product offerings, MRLs that support the target crops, and the ability to absorb the costs of new product registration and premium positioning.

Table Of Contents

Contact Us